miR-181a decelerates proliferation in cutaneous squamous cell carcinoma by targeting the proto-oncogene KRAS
Open Access
- 20 September 2017
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 12 (9) , e0185028
Abstract
Cutaneous squamous cell carcinoma (SCC) is the second most common human skin cancer with a rapidly increasing incidence among the Caucasian population. Among the many regulators, responsible for cancer progression and growth, microRNAs (miRNA) are generally accepted as key players by now. In our current study we found that microRNA-181a (miR-181a) shows low abundance in SCC compared to normal epidermal skin. In vitro, miRNA downregulation in normal primary keratinocytes induced increased proliferation, while in vivo miR-181a downregulation in HaCaT normal keratinocytes showed tumor-like growth increase up to 50%. Inversely, upregulation of these miRNAs in cancer cells lead to reduced cellular proliferation and induction of apoptosis in vitro. An in vivo therapeutic model with induced miR-181a expression in SCC13 cancer cells reduced tumor formation in mice by 80%. Modulation of miR-181a levels showed an inverse correlation with the proto-oncogene KRAS both on mRNA and protein level by direct interaction. Knockdown of KRAS mimicked the anti-proliferative effects of miR-181a overexpression in patient-derived SCC cells and abolished the enhanced viability of HaCaT cells following miR-181a knockdown. Furthermore, phospho-ERK levels correlated with KRAS levels, suggesting that the observed effects were mediated via the MAPK signaling pathway. miR-181a seemed regulated during keratinocyte differentiation probably in order to amplify the tumor suppressive character of differentiation. Taken together, miR-181a plays a crucial tumor suppressive role in SCC by targeting KRAS and could be a promising candidate for a miRNA based therapy.Keywords
Funding Information
- Hartmann-Müller Stiftung (1688)
- EMDO
This publication has 48 references indexed in Scilit:
- Ingenol Mebutate Signals via PKC/MEK/ERK in Keratinocytes and Induces Interleukin Decoy Receptors IL1R2 and IL13RA2Molecular Cancer Therapeutics, 2015
- Swiss clinical practice guidelines on field cancerization of the skinSwiss Medical Weekly, 2014
- From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinomaJournal of Clinical Investigation, 2012
- Organ transplantation and skin cancer: basic problems and new perspectivesExperimental Dermatology, 2010
- MicroRNAs in CancerAnnual Review of Pathology: Mechanisms of Disease, 2009
- The evolution of gene regulation by transcription factors and microRNAsNature Reviews Genetics, 2007
- Skin Cancers after Organ TransplantationNew England Journal of Medicine, 2003
- Clinicopathologic Variants of Cutaneous Squamous Cell CarcinomaAdvances in Anatomic Pathology, 2001
- A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma.Proceedings of the National Academy of Sciences, 1991
- Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system.Molecular and Cellular Biology, 1987